Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 53.11x is 85% above its estimated 4-year average of 28.64x, near the low end of its estimated 4-year range (0.10x–236.61x).
As of 2026-10-06T21:18:22.729Z. 76.40% above its estimated 12-month average of 30.11x.
Calculation as of: 2026-10-06T21:18:22.729Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ffcae252daa6a300827ff3558097e5e2d7e407771ad67afba685997be4cf909d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
53.11x
EV/SALES RATIO AVG TTM
30.11x
EV/SALES RATIO AVG 3Y
26.08x
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+76.40%
CURRENT VS 3Y AVG
+103.64%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.38x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
+1112.56%
vs the sector median at left
Stoke Therapeutics, Inc.
Market Cap
$1.57B
EV/Sales Ratio
53.11x
TTM Avg
30.11x
3Y Avg
26.08x
5Y Avg
N/A
Market Cap
$1.59B
EV/Sales Ratio
14.95x
TTM Avg
14.09x
3Y Avg
15.36x
5Y Avg
15.36x
Market Cap
$1.54B
EV/Sales Ratio
7.11x
TTM Avg
12.64x
3Y Avg
77.84x
5Y Avg
74.59x
Market Cap
$1.61B
EV/Sales Ratio
20.90x
TTM Avg
29.95x
3Y Avg
20.08x
5Y Avg
15.02x
Market Cap
$1.62B
EV/Sales Ratio
2.58x
TTM Avg
3.21x
3Y Avg
3.51x
5Y Avg
4.10x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | $1.57B | 53.11x | 30.11x | 26.08x | N/A |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | 14.95x | 14.09x | 15.36x | 15.36x |
| uniQure N.V. (QURE)vs › | $1.60B | 66.91x | 104.56x | 52.78x | 33.71x |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | 7.11x | 12.64x | 77.84x | 74.59x |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | 20.90x | 29.95x | 20.08x | 15.02x |
| Innoviva, Inc. (INVA)vs › | $1.54B | 2.79x | 3.82x | 4.31x | 4.24x |
| Septerna Inc (SEPN)vs › | $1.61B | 15.63x | 136.36x | 318.32x | 318.32x |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 1.22x | 1.48x | 1.49x | 2.56x |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | 2.58x | 3.21x | 3.51x | 4.10x |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 1.63x | 2.04x | 2.46x | 2.70x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 56.70x |
| 2026-10-02 | 57.42x |
| 2026-10-01 | 58.35x |
| 2026-09-30 | 58.33x |
| 2026-09-29 | 58.04x |
| 2026-09-28 | 57.13x |
| 2026-09-25 | 55.46x |
| 2026-09-24 | 56.63x |
| 2026-09-23 | 58.59x |
| 2026-09-22 | 65.99x |
| 2026-09-21 | 63.23x |
| 2026-09-18 | 64.14x |
| 2026-09-17 | 65.34x |
| 2026-09-16 | 62.90x |
| 2026-09-15 | 63.47x |
| 2026-09-14 | 66.94x |
| 2026-09-11 | 65.58x |
| 2026-09-10 | 66.32x |
| 2026-09-09 | 67.71x |
| 2026-09-08 | 68.02x |
| 2026-09-04 | 67.44x |
| 2026-09-03 | 67.88x |
| 2026-09-02 | 69.10x |
| 2026-09-01 | 70.03x |
| 2026-08-31 | 70.77x |
| 2026-08-28 | 71.78x |
| 2026-08-27 | 74.10x |
| 2026-08-26 | 75.29x |
| 2026-08-25 | 76.18x |
| 2026-08-24 | 73.45x |
| 2026-08-21 | 73.38x |
| 2026-08-20 | 71.25x |
| 2026-08-19 | 75.15x |
| 2026-08-18 | 73.02x |
| 2026-08-17 | 73.00x |
| 2026-08-14 | 70.94x |
| 2026-08-13 | 71.03x |
| 2026-08-12 | 75.01x |
| 2026-08-11 | 74.98x |
| 2026-08-10 | 73.24x |
| 2026-08-07 | 74.38x |
| 2026-08-06 | 72.52x |
| 2026-08-05 | 72.52x |
| 2026-08-04 | 71.90x |
| 2026-08-03 | 53.36x |
| 2026-07-31 | 51.99x |
| 2026-07-30 | 54.31x |
| 2026-07-29 | 53.21x |
| 2026-07-28 | 53.03x |
| 2026-07-27 | 52.87x |
| 2026-07-24 | 52.85x |
| 2026-07-23 | 53.54x |
| 2026-07-22 | 52.18x |
| 2026-07-21 | 51.89x |
| 2026-07-20 | 49.67x |
| 2026-07-17 | 52.36x |
| 2026-07-16 | 52.48x |
| 2026-07-15 | 54.05x |
| 2026-07-14 | 52.52x |
| 2026-07-13 | 53.17x |
| 2026-07-10 | 56.94x |
| 2026-07-09 | 59.79x |
| 2026-07-08 | 59.44x |
| 2026-07-07 | 60.17x |
| 2026-07-06 | 59.01x |
| 2026-07-02 | 59.54x |
| 2026-07-01 | 59.56x |
| 2026-06-30 | 59.58x |
| 2026-06-29 | 58.93x |
| 2026-06-26 | 58.16x |
| 2026-06-25 | 55.02x |
| 2026-06-24 | 55.00x |
| 2026-06-23 | 56.41x |
| 2026-06-22 | 56.14x |
| 2026-06-18 | 56.19x |
| 2026-06-17 | 54.74x |
| 2026-06-16 | 52.56x |
| 2026-06-15 | 54.23x |
| 2026-06-12 | 53.88x |
| 2026-06-11 | 52.97x |
| 2026-06-10 | 51.24x |
| 2026-06-09 | 52.99x |
| 2026-06-08 | 52.26x |
| 2026-06-05 | 54.25x |
| 2026-06-04 | 54.46x |
| 2026-06-03 | 53.17x |
| 2026-06-02 | 51.63x |
| 2026-06-01 | 55.15x |
| 2026-05-29 | 56.02x |
| 2026-05-28 | 57.39x |
| 2026-05-27 | 57.08x |
| 2026-05-26 | 56.25x |
| 2026-05-22 | 52.93x |
| 2026-05-21 | 53.58x |
| 2026-05-20 | 54.82x |
| 2026-05-19 | 54.15x |
| 2026-05-18 | 52.32x |
| 2026-05-15 | 54.39x |
| 2026-05-14 | 56.90x |
| 2026-05-13 | 57.57x |
| 2026-05-12 | 59.12x |
| 2026-05-11 | 59.42x |
| 2026-05-08 | 59.91x |
| 2026-05-07 | 9.94x |
| 2026-05-06 | 10.10x |
| 2026-05-05 | 10.00x |
| 2026-05-04 | 10.38x |
| 2026-05-01 | 10.03x |
| 2026-04-30 | 9.92x |
| 2026-04-29 | 9.82x |
| 2026-04-28 | 10.11x |
| 2026-04-27 | 10.23x |
| 2026-04-24 | 10.33x |
| 2026-04-23 | 10.62x |
| 2026-04-22 | 10.93x |
| 2026-04-21 | 10.83x |
| 2026-04-20 | 11.10x |
| 2026-04-17 | 11.36x |
| 2026-04-16 | 10.75x |
| 2026-04-15 | 10.81x |
| 2026-04-14 | 10.91x |
| 2026-04-13 | 10.66x |
| 2026-04-10 | 10.43x |
| 2026-04-09 | 10.69x |
| 2026-04-08 | 10.60x |
| 2026-04-07 | 10.25x |
| 2026-04-06 | 9.94x |
| 2026-04-02 | 9.93x |
| 2026-04-01 | 9.69x |
| 2026-03-31 | 9.87x |
| 2026-03-30 | 9.62x |
| 2026-03-27 | 9.96x |
| 2026-03-26 | 10.23x |
| 2026-03-25 | 10.26x |
| 2026-03-24 | 9.75x |
| 2026-03-23 | 10.13x |
| 2026-03-20 | 10.17x |
| 2026-03-19 | 10.07x |
| 2026-03-18 | 9.38x |
| 2026-03-17 | 9.97x |
| 2026-03-16 | 9.29x |
| 2026-03-13 | 9.07x |
| 2026-03-12 | 10.01x |
| 2026-03-11 | 10.42x |
| 2026-03-10 | 10.54x |
| 2026-03-09 | 10.53x |
| 2026-03-06 | 9.72x |
| 2026-03-05 | 9.48x |
| 2026-03-04 | 9.42x |
| 2026-03-03 | 9.24x |
| 2026-03-02 | 10.07x |
| 2026-02-27 | 9.99x |
| 2026-02-26 | 9.74x |
| 2026-02-25 | 9.73x |
| 2026-02-24 | 9.73x |
| 2026-02-23 | 9.94x |
| 2026-02-20 | 9.38x |
| 2026-02-19 | 9.41x |
| 2026-02-18 | 8.44x |
| 2026-02-17 | 8.47x |
| 2026-02-13 | 8.70x |
| 2026-02-12 | 8.70x |
| 2026-02-11 | 8.79x |
| 2026-02-10 | 8.86x |
| 2026-02-09 | 8.73x |
| 2026-02-06 | 8.84x |
| 2026-02-05 | 8.30x |
| 2026-02-04 | 8.73x |
| 2026-02-03 | 9.24x |
| 2026-02-02 | 8.38x |
| 2026-01-30 | 8.26x |
| 2026-01-29 | 8.46x |
| 2026-01-28 | 7.99x |
| 2026-01-27 | 8.02x |
| 2026-01-26 | 7.95x |
| 2026-01-23 | 8.01x |
| 2026-01-22 | 8.17x |
| 2026-01-21 | 8.02x |
| 2026-01-20 | 7.79x |
| 2026-01-16 | 7.79x |
| 2026-01-15 | 7.95x |
| 2026-01-14 | 8.44x |
| 2026-01-13 | 8.32x |
| 2026-01-12 | 7.99x |
| 2026-01-09 | 8.97x |
| 2026-01-08 | 9.21x |
| 2026-01-07 | 9.63x |
| 2026-01-06 | 9.65x |
| 2026-01-05 | 8.89x |
| 2026-01-02 | 8.42x |
| 2025-12-31 | 8.66x |
| 2025-12-30 | 8.68x |
| 2025-12-29 | 8.78x |
| 2025-12-26 | 8.71x |
| 2025-12-24 | 8.78x |
| 2025-12-23 | 8.69x |
| 2025-12-22 | 9.16x |
| 2025-12-19 | 8.72x |
| 2025-12-18 | 8.71x |
| 2025-12-17 | 8.97x |
| 2025-12-16 | 9.19x |
| 2025-12-15 | 9.01x |
| 2025-12-12 | 8.84x |
| 2025-12-11 | 9.04x |
| 2025-12-10 | 9.34x |
| 2025-12-09 | 8.29x |
| 2025-12-08 | 9.01x |
| 2025-12-05 | 8.41x |
| 2025-12-04 | 8.46x |
| 2025-12-03 | 8.43x |
| 2025-12-02 | 8.11x |
| 2025-12-01 | 8.19x |
| 2025-11-28 | 8.42x |
| 2025-11-26 | 8.50x |
| 2025-11-25 | 8.11x |
| 2025-11-24 | 8.26x |
| 2025-11-21 | 7.97x |
| 2025-11-20 | 7.57x |
| 2025-11-19 | 7.73x |
| 2025-11-18 | 7.85x |
| 2025-11-17 | 7.29x |
| 2025-11-14 | 7.16x |
| 2025-11-13 | 7.04x |
| 2025-11-12 | 6.77x |
| 2025-11-11 | 6.77x |
| 2025-11-10 | 5.98x |
| 2025-11-07 | 6.12x |
| 2025-11-06 | 6.01x |
| 2025-11-05 | 6.11x |
| 2025-11-04 | 6.90x |
| 2025-11-03 | 7.12x |
| 2025-10-31 | 8.27x |
| 2025-10-30 | 8.76x |
| 2025-10-29 | 8.67x |
| 2025-10-28 | 8.74x |
| 2025-10-27 | 9.14x |
| 2025-10-24 | 8.93x |
| 2025-10-23 | 8.75x |
| 2025-10-22 | 9.00x |
| 2025-10-21 | 9.63x |
| 2025-10-20 | 9.62x |
| 2025-10-17 | 9.29x |
| 2025-10-16 | 9.48x |
| 2025-10-15 | 9.90x |
| 2025-10-14 | 9.70x |
| 2025-10-13 | 8.36x |
| 2025-10-10 | 8.32x |
| 2025-10-09 | 8.23x |
| 2025-10-08 | 8.41x |
| 2025-10-07 | 7.48x |
| 2025-10-06 | 7.33x |
| 2025-10-03 | 6.97x |
| 2025-10-02 | 6.75x |
| 2025-10-01 | 6.39x |
| 2025-09-30 | 6.36x |
| 2025-09-29 | 6.72x |
| 2025-09-26 | 6.55x |
| 2025-09-25 | 6.20x |
| 2025-09-24 | 6.17x |
| 2025-09-23 | 6.11x |
Showing the most recent 260 of 1,057 data points. The chart above shows the full history.
